BYND Stock A Buy Right Now? Earnings, Beyond Meat Stock Chart Show This

Daily Updates

Since its start over 10 years ago, Beyond Meat (BYND) has emerged as the leader in plant-based meat alternatives. The vegan meat company’s product line can now be found in more than 84 countries in 112,000 retail and food service locations. After its May 2019 IPO launch, BYND stock rocketed 859% to all-time highs a few months later.


But Beyond Meat stock has dramatically retreated from those levels. It also has struggled to stay above a key support area, the 50-day moving average.

The action comes amid increased competition in the vegan meat retail category. And Beyond Meat is pivoting its retail strategy this year as coronavirus shutdowns strangled restaurant sales.

But is BYND stock a buy now? It’s key to analyze the vegan meat company’s fundamental and technical picture first.

Beyond Meat Stock Earnings

Beyond Meat posted disappointing Q3 earnings results on Nov. 9. The vegan meat maker reported an adjusted loss of 28 cents a share on revenue of $94.4 million, up just 2.7% from last year. Analysts expected Beyond Meat earnings of 3 cents a share on revenue of $135.56 million.

After the results were announced, BYND stock plunged to hit a six-month low in intraday trade before paring its losses.

“We experienced the full brunt and unpredictability of Covid-19’s impact for the first time in Q3,” CEO Ethan Brown stated on the earnings call.

Brown said the drop in Q3 revenue was driven by the lack of panic purchases and stockpiling made by consumers at the onset of the coronavirus pandemic.

“In light of what we view as transitory Covid-related factors, contrasted with enduring strengths of our business, we have not blinked in our focus on the exciting long-term growth path ahead of us,” Brown said.

BYND Stock News: Beyond Meat Partners With McDonald’s For ‘McPlant’ Products

On Nov. 9, fast food giant McDonald’s (MCD) announced it would begin offering McPlant menu items. The expansion of McDonald’s vegetarian menu options comes after a test run in Canada with Beyond Meat products.

But BYND stock didn’t get a meaningful boost from the McPlant news. McDonald’s did not cite any third-party involvement in the development of its vegetarian menu.

However, shares of Beyond Meat slightly recovered after the company told CNBC it’s partnering with McDonald’s on the meatless McPlant items.

The McDonald’s collaboration is one of several key partnerships in Beyond Meat’s expansion plans. CEO Brown announced on the Nov. 9 earnings call that Beyond Burger would be available at 7,000 CVS (CVS) locations nationwide in January 2021.

Additionally, Beyond Meat said on Sept. 8 it’s building production facilities outside Shanghai, China. This makes Beyond the first foreign vegan meat company to set up operations in the country.

Beyond Meat Expands To China

Plans for China-based production come a month after the launch of a new e-commerce site for Beyond Meat. The platform allows consumers to purchase vegan meat products directly from the company.

Aside from this new direct-to-consumer initiative, Beyond Meat’s growth agenda hinges on expanded retail partnerships and investments in the U.S. and Asia.

The vegan meat company also expanded its food service partnerships in the U.S. Beyond Meat products recently have been added to 650 Wawa convenience stores. Beyond Meat plans on continuing trials of plant-based meat products at select KFC and Dunkin’ Donuts locations, owned by parent companies Yum Brands (YUM) and Dunkin’ Brands (DNKN), respectively.

In Asia this year, Beyond Meat began collaborating with Yum China (YUMC)-owned restaurants — including KFC, Pizza Hut and Taco Bell. The plant-based-burger maker also has netted key partnerships with Alibaba‘s (BABA) Freshippo grocery stores.

“In Asia, our goal of establishing a production footprint before the end of 2020 remains on track,” Brown said. “We believe the magnitude of the opportunity in Asia merits significant investments, and we will continue to proceed with a sense of urgency appropriate for the challenge and opportunity alike.”

Growth Of Vegan Meat Market

Credit Suisse says Beyond Meat is well-positioned in the fake-meat market.

“Beyond may emerge as a net beneficiary of the pandemic in the near term due to strong demand in (the) retail channel (48% of sales) and in the long term due to rising consumer interest in healthier foods,” Credit Suisse analyst Robert Moskow wrote in a June report.

Though plant-based meat substitute is a relatively new industry, Barclays analysts in May projected sales of vegan meat could hit $140 billion in the next 10 years.

Beyond Meat’s most notable rival is privately owned Impossible Foods. In addition to successful restaurant partnerships that include Burger King (QSR), the Northern California-based company also has aggressively expanded its own retail footprint during the pandemic.

Impossible Foods has grown its grocery retailer roster from 150 locations to more than 5,000 since the beginning of March. That includes deals with Walmart and Albertsons (ACI).

The country’s largest meat producer, Tyson Foods (TSN), also entered the vegan meat space in 2019. Tyson sells plant-based meat in the form of nuggets and blended protein alternatives through its Raised & Rooted label in more than 7,000 stores across the U.S.

BYND Stock Fundamental Analysis

To determine whether BYND stock is a buy now, fundamental and technical analysis is key.

The IBD Stock Checkup tool shows that BYND stock has an IBD Composite Rating of 13 out of a best-possible 99. The rating measures a stock based on the most important fundamental and technical stock-picking criteria. IBD research shows some of the greatest stock winners of all time often have a Composite Rating of at least 95 near the start of big runs.

The Composite Rating looks at earnings and sales growth, profit margins, return on equity and relative stock price performance, among other metrics.

BYND stock has an EPS Rating of 7 out of 99. The EPS rating compares a stock’s quarterly and annual earnings-per-share growth with that of all other stocks.

The plant-based meat producer ranks No. 7 vs. its food retail peers in terms of Composite Rating. Recent IPO Vital Farms (VITL) ranks at the top. Cal-Maine Foods (CALM) currently holds the No. 2 ranking in IBD’s Food-Meat Products industry group. Tyson Foods (TSN) is No. 3.

But the group is currently ranked a dismal No. 195 out of the 197 industry groups that IBD tracks. Investors should focus on stocks in the top quartile of IBD’s groups.

BYND Stock Technical Analysis

BYND stock made its Nasdaq debut in May 2019 at 25. Shares of Beyond Meat quickly made a strong move in the following three months.

Beyond Meat stock hit an all-time high of 239.71 in July 2019. But then BYND began declining almost as quickly as it climbed.

The most definitive signal for investors to take their profits from the IPO move came that August when shares closed below their 50-day moving average line. BYND stock then underperformed the overall market the rest of 2019.

BYND stock was able to retake its 50-day line in January 2020 but slid back below that level amid the coronavirus crash. Shares of Beyond Meat proceeded to hit a bottom of 48.18 on March 19.

BYND made a powerful move from those lows. It cleared a 158.70 handle buy point in late September and powered above a cup entry of 167.26 soon after.

Shares then climbed as much as 18% before pulling back to — and undercutting — the 21-day exponential moving average. The stock then plunged to six-month lows after earnings on Nov. 9.

It’s now falling below its 200-day moving average.

The relative strength line for BYND stock has hit a seven-month low. The RS line tracks a stock’s performance vs. the S&P 500 index.

Beyond Meat Stock: Is It A Buy Right Now?

The long-term outlook for plant-based meat looks compelling, and Beyond Meat is navigating a shift in retail strategy amid the ongoing pandemic. Forward-looking earnings estimates are compelling and the chart’s technical picture has improved.

Bottom line: BYND stock is not a buy right now. Shares have round-tripped since breaking out of a cup base and are now getting support at the 200-day line.

To find the best stocks to buy and watch, check out IBD’s Stock Lists page. More stock ideas can be found on our Leaderboard and MarketSmith platforms.

Follow Alexis Garcia on Twitter at @IBD_Alexis.


These Are The 5 Best Stocks To Buy And Watch Now

IBD Live: Follow The Market With Investing Pros

Find Compelling Growth Stocks With IBD’s Stock Of The Day

Catch The Next Big Winning Stock With MarketSmith

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *